Search Results
Apr 01, 2026, 03:10 ET Hyatt Advances Next Phase of Growth in India and Southwest Asia with New Senior Leadership Appointment
premium travel, luxury experiences, and differentiated dining align closely with Hyatt's strengths in luxury and lifestyle, experiential offerings and F&B. This has powered Hyatt's growth in the region, with deals signed in 2025 contributing nearly 5,000 rooms to its India and Southwest Asia pipeline.Building
More news about: Hyatt Hotels India & Southwest Asia
Apr 01, 2026, 02:00 ET KAIJU NO. 8 THE GAME: Young Talents Awaken in Main Story Chapter 10. New ★5 Haruichi Izumo Debuts Alongside 1,500 Dimensional Crystal Rewards in New Chapter Event!
https://games.aktsk.jp/en/Founded: December 2021Representative: CEO Yuki TotsukaHeadquarters: 8F oak meguro, 2-13-30 Kamiosaki, Shinagawa-ku, Tokyo, JapanBusiness Activities: Game Development & OperationsPlease be sure to
More news about: Akatsuki Games Inc.
Mar 31, 2026, 22:02 ET Abbisko Therapeutics' FGFR4 Inhibitor Irpagratinib Granted Orphan Drug Designation by EMA for Hepatocellular Carcinoma
overexpression.In addition to monotherapy, Abbisko Therapeutics is exploring irpagratinib in combination with atezolizumab, an anti-PD-L1 antibody manufactured by F. Hoffmann-La Roche and Roche (China), in a Phase II study. At the the 2025 ESMO GI Congress, Abbisko presented clinical data showing that the combination
More news about: Abbisko
Mar 31, 2026, 17:23 ET Cellebrite annonce sa MàJ du printemps 2026 : accès aux nouveaux appareils à la pointe de l'industrie et expansion multicloud
cybersécurité et d'autres facteurs affectant son activité et ses opérations, y compris ceux discutés dans le rapport annuel de Cellebrite sur le formulaire 20-F pour l'exercice clos au 31 décembre 2025, déposé auprès de la Securities and Exchange Commission des États-Unis le 3 mars 2026, qui peut être consulté
More news about: Cellebrite
Mar 31, 2026, 17:00 ET Wheaton Precious Metals Provides Details of Annual and Special Meeting of Shareholders and Files Form 40-F
Metals™ Corp. ("Wheaton" or the "Company") announces that its Form 40-F report has been filed with the Securities and Exchange Commission and is available on EDGAR. The Company's 2025 audited financial statements, along with its Form 40-F, are also available on the Company's website at
More news about: Wheaton Precious Metals Corp.
Mar 31, 2026, 17:00 ET DeFi Technologies Announces Preliminary Unaudited Full Year 2025 Financial Results with Record Revenue of $99.1 Million and Record Net Income of $62.7 Million; Appoints New Independent Chair of the Audit Committee
which orders that the trading of securities of the Company will cease.In addition, the Company intends to file its 2025 Annual Report on Form 40-F, including the Annual Filings, with the U.S. Securities and Exchange Commission (the "SEC") on EDGAR at the same time the Annual Filings are filed with
More news about: DeFi Technologies Inc.
Mar 31, 2026, 17:00 ET DeFi Technologies Announces Preliminary Unaudited Full Year 2025 Financial Results with Record Revenue of $99.1 Million and Record Net Income of $62.7 Million; Appoints New Independent Chair of the Audit Committee
which orders that the trading of securities of the Company will cease.In addition, the Company intends to file its 2025 Annual Report on Form 40-F, including the Annual Filings, with the U.S. Securities and Exchange Commission (the "SEC") on EDGAR at the same time the Annual Filings are filed with
More news about: DeFi Technologies Inc.
Mar 31, 2026, 16:30 ET Tantech Holdings Ltd Announces Pricing and Closing of $2.15 Million Registered Direct Offering and Private Placements
in a registered direct offering. In a concurrent private placement, the Company also issued to the same investors Series E Common Warrants and Series F Common Warrants. Aggregate gross proceeds to the Company from both transactions were approximately $2.15 million. The transactions closed on March 31,
More news about: Tantech Holdings Ltd.
Mar 31, 2026, 16:15 ET Galmed Pharmaceuticals Ltd. Files Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2025
biopharmaceutical company for liver, cardiometabolic diseases and GI oncological therapeutics, today announced that it has filed its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the U.S. Securities and Exchange Commission (the 'SEC').
More news about: Galmed Pharmaceuticals Ltd.
Mar 31, 2026, 14:23 ET South Seas purchases Rauschenberg property on Captiva
https://prioritymarketing.sharefile.com/public/share/web-s9c61b3efe3044298a5e49f864de295cd
More news about: South Seas
Mar 31, 2026, 14:00 ET TRATON 그룹과 Applied Intuition, TRATON의 4개 글로벌 브랜드 전반에 걸쳐 차량 가동 시간을 향상시키는 통합 소프트웨어 플랫폼 'TRATON ONE OS' 발표
content:https://www.prnewswire.com/kr/news-releases/u0074u0072u0061u0074u006Fu006Eu002DuADF8uB8F9uACFCu002Du0061u0070u0070u006Cu0069u0065u0064u002Du0069u006Eu0074u0075u0069u0074u0069u006Fu006E-302729544.htmlSOURCE
More news about: Applied Intuition, Inc.
Mar 31, 2026, 11:16 ET Applied Medical Technology, Inc. Expands MiniSPC® Button, a Low Profile Suprapubic Catheter
The MiniSPC® Button is now available in 12F, 20F, and 24F, expanding the overall portfolio to include 12F, 14F, 16F, 18F, 20F, and 24F. The product line also features a wide range of stoma lengths from 0.8 cm to 10.0 cm, enabling clinicians
More news about: Applied Medical Technology, Inc.
Mar 31, 2026, 10:58 ET Nordea Bank Abp: Repurchase of own shares on 27.03.2026
https://mb.cision.com/Public/434/4328144/842ab3b84247b9f8.xlsxNordea-statement-of-transactions-in-own-shares-20260327
More news about: Nordea
Mar 31, 2026, 10:50 ET Why Rare Earth Magnets are the World's Most Dangerous Bottleneck
Microsoft Corporation (NASDAQ: MSFT), General Motors Company (NYSE: GM), Western Digital Corporation (NASDAQ: WDC). A single F-35 carries roughly 435 kilograms of these materials. MRI machines need them to power today's medical imaging. They're in the guidance systems on missiles,
More news about: OilPrice.com
Mar 31, 2026, 10:20 ET Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
and (ii) the completion of the Company's previously announced proposed public offering in the United States pursuant to its registration statement on F-1 filed with the U.S. Securities and Exchange Commission, as amended. The Debenture will be secured by the general security agreement already entered
More news about: Innocan Pharma Corporation
Mar 31, 2026, 10:20 ET Innocan Pharma Announces Offering of an Additional Debenture to Tamar Innovest
and (ii) the completion of the Company's previously announced proposed public offering in the United States pursuant to its registration statement on F-1 filed with the U.S. Securities and Exchange Commission, as amended. The Debenture will be secured by the general security agreement already entered
More news about: Innocan Pharma Corporation
Mar 31, 2026, 10:00 ET FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX ANNOUNCES ON-SALE TICKET TIMELINE AND TICKET OPTIONS FOR 2026 RACE, NOV. 19-21
offerings, a dedicated service manager for assistance year-round and access to F1 activations and entertainment within the fan zones.Luxury Hospitality: Gordon Ramsay at F1® Garage (starting at $28,885 including taxes and fees)Wynn
More news about: FORMULA 1 HEINEKEN LAS VEGAS GRAND PRIX
Mar 31, 2026, 10:00 ET Ford and onX Give Owners a Complimentary Year of Off-Road Navigation
appsMISSOULA, Mont., March 31, 2026 /PRNewswire/ -- From Explorer Tremor to F-150 Raptor R, Ford Motor Company offers vehicles ready for adventure. Now,
More news about: onX
Mar 31, 2026, 09:37 ET 셀레브라이트 스프링 릴리즈: 업계 최고 수준의 기기 접근성 및 멀티 클라우드 확장
의존도, 규제 및 준수 의무, 사이버 보안 리스크, 그리고 2026년 3월 3일 미국 증권거래위원회(U.S. Securities and Exchange Commission)에 제출된 2025년 12월 31일 종료 회계연도에 대한 셀레브라이트의 연례 보고서(Form 20-F) 에서 논의된 기타 사업 및 운영 관련 요인이 포함되며, 해당 보고서는 www.sec.gov에서 무료로 열람할 수 있다.셀레브라이트는 법적으로 요구되는 경우를 제외하고는
More news about: Cellebrite
Mar 31, 2026, 09:25 ET Xiao-I Corporation Provides Further Update on Shanghai Xiao-I's Patent Infringement Lawsuit Against Apple
Additional factors are discussed in the Company's filings with the SEC, including under the section entitled "Risk Factors" in its annual report on Form 20-F filed with the SEC on April 30, 2024, as well as its current reports on Form 6-K and other filings, all of which are available for review at
More news about: Xiao-I Corporation
Mar 31, 2026, 09:22 ET Cellebrite: Nuevo acceso a dispositivos líder en la industria y expansión multicloud
ciberseguridad; y otros factores que afectan su negocio y operaciones, incluidos los que se describen en el Informe Anual de Cellebrite en el Formulario 20-F para el año finalizado el 31 de diciembre de 2025, presentado ante la Comisión de Bolsa y Valores de Estados Unidos el 3 de marzo de 2026, al que se puede
More news about: Cellebrite
Mar 31, 2026, 09:20 ET NeuroSense Therapeutics Reports Year End 2025 Financial Results and Provides Business Update
million.A summary of NeuroSense's consolidated financial results is included in the tables below.A copy of the Company's annual report on Form 20-F for the year ended December 31, 2025 has been filed with the U.S. Securities and Exchange Commission at https://www.sec.gov/
More news about: NeuroSense
Mar 31, 2026, 09:15 ET Cellebrite Spring Release: Neuer branchenführender Gerätezugang und Multi-Cloud-Erweiterung
sich auf das Geschäft und die Geschäftstätigkeit von Cellebrite auswirken, einschließlich derer, die im Jahresbericht von Cellebrite auf Formblatt 20-F für das am 31. Dezember 2025 endende Jahr erörtert werden, der am 3. März 2026 bei der US-Börsenaufsichtsbehörde (Securities and Exchange Commission)
More news about: Cellebrite
Mar 31, 2026, 09:05 ET Canaan Inc. to Present at Jefferies Virtual Power x Data Center Conference
Inc. may also make written or oral forward-looking statements in its periodic reports to the U.S. Securities and Exchange Commission ("SEC") on Forms 20-F and 6-K, in its annual report to shareholders, in press releases and other written materials and in oral statements made by its officers, directors or
More news about: Canaan Inc.
Mar 31, 2026, 09:00 ET RTX's Pratt & Whitney awarded $6.6 billion F135 production contract to definitize lots 18-19
of the F135 engine, which powers all three variants of the F-35 Lightning II. This modification definitizes lot 18 F135 propulsion system production, as well as provides for the production of F135 propulsion systems in support of lot 19 F-35 aircraft production. The total value of the F135 lots
More news about: RTX